1. Home
  2. PAHC vs MNKD Comparison

PAHC vs MNKD Comparison

Compare PAHC & MNKD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Phibro Animal Health Corporation

PAHC

Phibro Animal Health Corporation

HOLD

Current Price

$52.69

Market Cap

1.7B

Sector

Health Care

ML Signal

HOLD

Logo MannKind Corporation

MNKD

MannKind Corporation

HOLD

Current Price

$2.52

Market Cap

1.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PAHC
MNKD
Founded
1946
1991
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.7B
1.7B
IPO Year
2014
2004

Fundamental Metrics

Financial Performance
Metric
PAHC
MNKD
Price
$52.69
$2.52
Analyst Decision
Hold
Buy
Analyst Count
3
7
Target Price
$34.33
$8.64
AVG Volume (30 Days)
222.4K
6.8M
Earning Date
05-06-2026
05-07-2026
Dividend Yield
0.92%
N/A
EPS Growth
1883.33
N/A
EPS
1.32
0.02
Revenue
$833,350,000.00
$348,966,000.00
Revenue This Year
$17.03
$33.40
Revenue Next Year
$3.82
$16.48
P/E Ratio
$39.62
$130.25
Revenue Growth
4.12
22.23
52 Week Low
$16.16
$2.52
52 Week High
$56.30
$6.51

Technical Indicators

Market Signals
Indicator
PAHC
MNKD
Relative Strength Index (RSI) 59.22 20.97
Support Level $37.09 N/A
Resistance Level $56.14 $6.18
Average True Range (ATR) 2.28 0.15
MACD -0.16 0.03
Stochastic Oscillator 73.36 5.81

Price Performance

Historical Comparison
PAHC
MNKD

About PAHC Phibro Animal Health Corporation

Phibro Animal Health Corp operates as a diversified animal health and mineral nutrition company. It develops, manufactures, and markets products for a range of food animals comprising poultry, swine, beef and dairy cattle, and aquaculture. The product portfolio of the company includes animal health products such as antibacterials, anticoccidials, nutritional specialty products and vaccines, and mineral nutrition products. The company operates through three segments, Animal Health, Mineral Nutrition, and Performance Products, of which key revenue is derived from the Animal Health segment which relates to the development, manufacturing, and marketing of antibacterials, nutritional specialty products, and vaccines. The entity sells its products in the U.S. and other international countries.

About MNKD MannKind Corporation

MannKind Corp is a biopharmaceutical company focused on the development and commercialization of inhaled therapeutic products for patients with diseases such as diabetes and pulmonary arterial hypertension. Its approved product, Afrezza (insulin human) Inhalation Powder, is an ultra-rapid-acting inhaled insulin used to improve glycemic control in adults with diabetes. The product consists of a dry powder formulation of human insulin delivered from a small portable inhaler.

Share on Social Networks: